SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-063763
Filing Date
2024-05-23
Accepted
2024-05-23 09:00:04
Documents
8
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A atos_def14a_2024.htm DEF 14A 1019076
2 GRAPHIC img133004830_0.jpg GRAPHIC 3754
3 GRAPHIC img133004830_1.jpg GRAPHIC 3171
4 GRAPHIC img133004830_2.jpg GRAPHIC 3754
5 GRAPHIC img133004830_3.jpg GRAPHIC 158808
6 GRAPHIC img133004830_4.jpg GRAPHIC 153024
7 GRAPHIC img133004830_5.jpg GRAPHIC 378115
8 GRAPHIC img133004830_6.jpg GRAPHIC 363982
  Complete submission text file 0000950170-24-063763.txt   2486405
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35610 | Film No.: 24975326
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)